Pharma Company Bags New Rs 44 Crore Order From United Nations International Children's Emergency Fund (UNICEF)
Pharma Company Bags New Rs 44 Crore Order From United Nations International Children's Emergency Fund (UNICEF)

Pharma Company Bags New Rs 44 Crore Order From United Nations International Children's Emergency Fund (UNICEF)

The company has a market cap of over Rs 3,000 crore and the stock gave multibagger returns of 382 per cent from its 52-week low of Rs 112.35 per share.

DSIJ Intelligence-1 Article rating: 3.3

The company has a market cap of over Rs 3,000 crore and the stock gave multibagger returns of 382 per cent from its 52-week low of Rs 112.35 per share.

COVID Vaccine Sputnik V Manufacturer Hits Upper Circuit, Secures Rs 127 Crore Order from UNICEF – FIIs and DIIs Increase Stake
COVID Vaccine Sputnik V Manufacturer Hits Upper Circuit, Secures Rs 127 Crore Order from UNICEF – FIIs and DIIs Increase Stake

COVID Vaccine Sputnik V Manufacturer Hits Upper Circuit, Secures Rs 127 Crore Order from UNICEF – FIIs and DIIs Increase Stake

The company’s shares have delivered an impressive return of over 220 per cent in the past year.

DSIJ Intelligence Article rating: 5.0

In Q2FY25 the company reported a net profit of Rs 4.71 crore compared to a loss of Rs 8.29 crore

COVID Vaccine Sputnik V Manufacturing Stock Hits Upper Circuit Today, FIIs Increase Stake in Q1 – Stock Delivered Multibagger Return in Just 1 Month!
COVID Vaccine Sputnik V Manufacturing Stock Hits Upper Circuit Today, FIIs Increase Stake in Q1 – Stock Delivered Multibagger Return in Just 1 Month!

COVID Vaccine Sputnik V Manufacturing Stock Hits Upper Circuit Today, FIIs Increase Stake in Q1 – Stock Delivered Multibagger Return in Just 1 Month!

The company’s shares have delivered a multibagger return of over 140 per cent to its shareholders in just 6 months.

DSIJ Intelligence Article rating: 3.8

The world’s first registered COVID-19 vaccine, Sputnik V, earlier signed an agreement with the Russian Direct Investment Fund (RDIF) to manufacture 100 million doses per year.

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR